ROIVW - Roivant Sciences GAAP EPS of -$0.38 misses by $0.07 revenue of $21.62M misses by $2.87M
2023-08-14 07:27:35 ET
- Roivant Sciences press release ( NASDAQ: ROIV ): FQ1 GAAP EPS of -$0.38 misses by $0.07 .
- Revenue of $21.62M (+400.5% Y/Y) misses by $2.87M .
- Roivant reported its consolidated cash, cash equivalents and restricted cash of $1.4B at June 30, 2023, supporting cash runway into the second half of calendar year 2025.
For further details see:
Roivant Sciences GAAP EPS of -$0.38 misses by $0.07, revenue of $21.62M misses by $2.87M